Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASR | P41180 | 10/20 | 0.40 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.39 |
| ▸ | ITGAV | P06756 | 1/20 | 0.39 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.39 |
| ▸ | DRD2 | P14416 | 5/20 | 0.39 |
| ▸ | DRD3 | P35462 | 5/20 | 0.39 |
| ▸ | HPGDS | O60760 | 2/20 | 0.38 |
| ▸ | CNR1 | P21554 | 1/20 | 0.38 |
| ▸ | CNR2 | P34972 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | GFER | P55789 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6801434 | 0.92 | ITGB3 (0.43) | CASRITGB3ITGAVITGA2BDRD2 | |
| SCHEMBL7540509 | 0.92 | CASR (0.42) | CASRITGB3ITGAVITGA2BDRD2 | |
| SCHEMBL6800147 | 0.83 | ITGB3 (0.45) | CASRITGB3ITGAVITGA2BDRD2 | |
| SCHEMBL6801441 | 0.82 | ALDH1A1 (0.41) | CASRITGB3ITGAVITGA2BDRD2 | |
| SCHEMBL6796225 | 0.81 | CASR (0.44) | CASRITGB3ITGAVITGA2BDRD2 | |
| SCHEMBL6799964 | 0.80 | DRD2 (0.39) | CASRITGB3ITGAVITGA2BDRD2 | |
| SCHEMBL6797577 | 0.79 | ITGB3 (0.47) | ITGB3ITGAVITGA2BALDH1A1 | |
| SCHEMBL381765 | 0.78 | ALDH1A1 (0.46) | CASRDRD2DRD3HPGDSCNR1 | |
| SCHEMBL381767 | 0.77 | ITGB3 (0.51) | CASRITGB3ITGAVITGA2BDRD2 | |
| SCHEMBL6800155 | 0.76 | ALDH1A1 (0.44) | CASRITGB3ITGAVITGA2BDRD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6750219-B1 | HAVING INTEGRIN ALPHA V BETA 3 ANTAGONISTIC ACTIVITY, GP IIB/IIIA ANTAGONISTIC ACTIVITY, AND/OR HUMAN PLATELET AGGREGATION INHIBITORY ACTIVITY AND ALSO HAVING EXCELLENT WATER SOLUBILITY | MEIJI SEIKA KAISHA, LTD. (JP) | 2004-06-15 | — | — | US | claimed |
| US-6750219-B1 | HAVING INTEGRIN ALPHA V BETA 3 ANTAGONISTIC ACTIVITY, GP IIB/IIIA ANTAGONISTIC ACTIVITY, AND/OR HUMAN PLATELET AGGREGATION INHIBITORY ACTIVITY AND ALSO HAVING EXCELLENT WATER SOLUBILITY | MEIJI SEIKA KAISHA, LTD. (JP) | 2004-06-15 | — | — | US | disclosed |